# Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

> **NCT05464082** · PHASE2 · RECRUITING · sponsor: **University of Utah** · enrollment: 80 (estimated)

## Conditions studied

- Breast Cancer Recurrent

## Interventions

- **OTHER:** Functional Precision Oncology

## Key facts

- **NCT ID:** NCT05464082
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-06
- **Primary completion:** 2026-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05464082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05464082, "Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05464082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*